Has Ronald Brazg received payments from drug or device companies?

Yes. Drug and device makers reported $28,751 in general payments to Ronald Brazg across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ronald Brazg did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ronald Brazg come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ronald Brazg

Endocrinology, Diabetes & Metabolism · Renton, WANPI 1194746131

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $19,881 of the $28,751 with a category attached, or 69.1%. 5 manufacturers reported payments, led by Senseonics, Incorporated at 35.1% of the total. Reporting peaked in 2019 at $7,685 and has fallen 53.0% since, to $3,612 in 2025. Among endocrinology, diabetes & metabolism clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,751in general payments, 2019–2025

Across 32 payments — averaging $898.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Senseonics, Incorporated$10K
Medtronic$10K
AbbVie$6K
Novo Nordisk AS$2K
Acella Pharmaceuticals, LLC$1K

$17,956,953in research payments, 2019–2025

Across 2,068 payments — averaging $8683.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$5M
Medtronic$4.1M
Senseonics, Incorporated$2.7M
Modernatx, Inc.$2.4M
Eli Lilly$1.3M
Roche Diabetes Care, Inc.$1.1M
plus $1.3M from 6 others

What the payments were for

Consulting fees$19,88169%
Speaking & faculty fees$4,38515%
Travel & lodging$4,10614%
Food & beverage$3791%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Senseonics, Incorporated	9	$10,092
Medtronic(2 entities)	12	$9,668
AbbVie	6	$6,300
Novo Nordisk AS	4	$1,505
Acella Pharmaceuticals, LLC	1	$1,185

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,751 in reported general payments places this provider in the 90th percentile of 161 endocrinology, diabetes & metabolism providers in Washington.

See all endocrinology, diabetes & metabolism providers in Washington →

Other endocrinology, diabetes & metabolism in Renton

Leslie KlaffRenton$2K
Michael ShannonLacey$698K
Lynn KohlmeierSpokane$518K
Carol WyshamSpokane$512K
Bruce WilsonRichland$352K
Irl HirschSeattle$192K
Biju KunhiramanYakima$118K
Nicole EhrhardtSeattle$111K
Kristina UtzschneiderSeattle$72K
Savitha SubramanianSeattle$71K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →